Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jon A Erickson

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|February 25, 2015
Fragment-based design of kinase inhibitors: a practical guideJon A Erickson
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 18, 2001
A pharmacophore for human pregnane X receptor ligandsSean Ekins, Jon A Erickson
Journal of Chemical Information and Modeling|October 25, 2007
Lessons in molecular recognition. 2. Assessing and improving cross-docking accuracyJeffrey J Sutherland, Ravi K Nandigam, Jon A Erickson, et al.
Journal of Combinatorial Chemistry|July 17, 2007
Solid-phase synthesis of novel trimers containing a phenylstatine core and analysis by high-resolution magic angle spinningLorena Taboada, Lourdes Prieto, Paloma Vidal, et al.
Journal of Medicinal Chemistry|December 30, 2003
Lessons in molecular recognition: the effects of ligand and protein flexibility on molecular docking accuracyJon A Erickson, Mehran Jalaie, Daniel H Robertson, et al.
Journal of Chemical Information and Modeling|December 5, 2008
Predicting the accuracy of ligand overlay methods with Random Forest modelsRavi K Nandigam, David A Evans, Jon A Erickson, et al.
Biochimica Et Biophysica Acta|December 17, 2009
Structure-guided expansion of kinase fragment libraries driven by support vector machine modelsJon A Erickson, Mary M Mader, Ian A Watson, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2003
Design and synthesis of statine-containing BACE inhibitorsJingdan Hu, Cynthia L Cwi, David L Smiley, et al.
ACS Medicinal Chemistry Letters|March 21, 2019
Idea2Data: Toward a New Paradigm for Drug DiscoveryChristos A Nicolaou, Christine Humblet, Hong Hu, et al.
Journal of Medicinal Chemistry|June 27, 2003
Novel potent 5-HT(1F) receptor agonists: structure-activity studies of a series of substituted N-[3-(1-methyl-4-piperidinyl)-1H-pyrrolo[3,2-b]pyridin-5-yl]amidesSandra A Filla, Brian M Mathes, Kirk W Johnson, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|February 25, 2015
Fragment-based design of kinase inhibitors: a practical guideJon A Erickson
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 18, 2001
A pharmacophore for human pregnane X receptor ligandsSean Ekins, Jon A Erickson
Journal of Chemical Information and Modeling|October 25, 2007
Lessons in molecular recognition. 2. Assessing and improving cross-docking accuracyJeffrey J Sutherland, Ravi K Nandigam, Jon A Erickson, et al.
Journal of Combinatorial Chemistry|July 17, 2007
Solid-phase synthesis of novel trimers containing a phenylstatine core and analysis by high-resolution magic angle spinningLorena Taboada, Lourdes Prieto, Paloma Vidal, et al.
Journal of Medicinal Chemistry|December 30, 2003
Lessons in molecular recognition: the effects of ligand and protein flexibility on molecular docking accuracyJon A Erickson, Mehran Jalaie, Daniel H Robertson, et al.
Journal of Chemical Information and Modeling|December 5, 2008
Predicting the accuracy of ligand overlay methods with Random Forest modelsRavi K Nandigam, David A Evans, Jon A Erickson, et al.
Biochimica Et Biophysica Acta|December 17, 2009
Structure-guided expansion of kinase fragment libraries driven by support vector machine modelsJon A Erickson, Mary M Mader, Ian A Watson, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2003
Design and synthesis of statine-containing BACE inhibitorsJingdan Hu, Cynthia L Cwi, David L Smiley, et al.
ACS Medicinal Chemistry Letters|March 21, 2019
Idea2Data: Toward a New Paradigm for Drug DiscoveryChristos A Nicolaou, Christine Humblet, Hong Hu, et al.
Journal of Medicinal Chemistry|June 27, 2003
Novel potent 5-HT(1F) receptor agonists: structure-activity studies of a series of substituted N-[3-(1-methyl-4-piperidinyl)-1H-pyrrolo[3,2-b]pyridin-5-yl]amidesSandra A Filla, Brian M Mathes, Kirk W Johnson, et al.
Pageof 2